A comparative clinical study on efficacy of bhavita amalaki choorna and shuddha guggulu in dyslipidemia
Journal name: Journal of Ayurveda and Holistic Medicine
Original article title: A comparative clinical study on efficacy of bhavita amalaki choorna and shuddha guggulu in dyslipidemia
The Journal of Ayurveda and Holistic Medicine (JAHM) promotes Ayurvedic scientific research by offering a platform for in-depth exploration and integration of its principles into modern healthcare. JAHM is owned and published by Atreya Ayurveda Publications. Atreya Ayurveda Publications engaged in scientific publications on Ayurveda in the form of print books and ebooks since 2007.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Journal of Ayurveda and Holistic Medicine:
Full text available for: A comparative clinical study on efficacy of bhavita amalaki choorna and shuddha guggulu in dyslipidemia
Year: 2016 | Doi: 10.70066/jahm.v4i4.315
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Background: Dyslipidemia, a lipoprotein metabolism disorder, contributes significantly to atherosclerosis leading to cardiovascular diseases, the major cause of morbidity and mortality in both developed as well as developing countries.
This calls for an urgent interventional strategy. Dyslipidemia being a chronic condition has to be managed by easily available, safe and effective medicines. Based on these facts, the present study was planned. Objectives: To evaluate and compare the efficacy of Bhavita Amalaki Choorna and Shuddha Guggulu in the management of dyslipidemia. Materials and Methods: In this interventional, active controlled, open labeled study, a total of 33 dyslipidemic subjects were alternatively allocated to receive Bhavita Amalaki Choorna (BA; n=16) and Shuddha Guggulu Vati (SG; n=17) in a dosage of 3grams twice daily with takra (buttermilk) as anupana half an hour before food for 3 months out of which a total of 30 completed the study. The assessment criteria were recorded at baseline and after treatment; assessed for the efficacy of the interventions. Results: BA elicited statistically significant results in HDL and SG elicited statistically significant results in Total Cholesterol, LDL and Triglycerides. Both the drugs elicited significant results in various other objective parameters. There were statistically significant differences found only in HDL between the group. Conclusion:
Both BA and SG can be effective prescriptions for the management of Dyslipidemia. Amalaki is having added benefit of being cost effective and easily available in most parts of India. Thus BA can be preferred over SG.
Other Science Concepts:
Discover the significance of concepts within the article: ‘A comparative clinical study on efficacy of bhavita amalaki choorna and shuddha guggulu in dyslipidemia’. Further sources in the context of Science might help you critically compare this page with similair documents:
Bhavana, Anupana, Emblica officinalis, Statistical analysis, Age-group, Clinical study, Ethical consideration, Swarasa, Body mass index, Oxidative stress, Kapha Prakriti, Atherosclerosis, Interventional study, Morbidity and Mortality, Dyslipidemia, Total cholesterol, High-density lipoprotein, Low-density lipoprotein, Shuddha Guggulu, High-density lipoprotein (HDL), Low-density lipoprotein (LDL), Drug compliance, Cost effective, Interventional clinical study, Hypocholesterolemic, Serum lipid levels, Bioactive constituents, Cost-effective treatment, Active controlled, Kapha dominant prakriti, Hypolipidemic action, Cardiovascular disease, Statistically significant result, Anthropometric measurement, Triglyceride, Biochemical parameter.